In the race to turn CAR-T cell therapies against autoimmune diseases, Cabaletta has always been blazing its own trail.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
In the race to turn CAR-T cell therapies against autoimmune diseases, Cabaletta has always been blazing its own trail.